A detailed history of Johnson Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 34 shares of DXCM stock, worth $2,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 4 750.0%
Holding current value
$2,332
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $3,309 - $4,213
30 Added 750.0%
34 $3,000
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $301 - $496
4 New
4 $0
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $2,175 - $4,252
32 New
32 $2,000
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $7,631 - $9,426
-90 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $7,020 - $9,405
90 New
90 $33,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.